David Olson
Contact
Professor, Faculty of Medicine & Dentistry - Obstetrics & Gynaecology Dept
- dmolson@ualberta.ca
- Phone
- (780) 492-8559
- Address
-
227D Heritage Medical Research Centre
11207 - 87 Ave NWEdmonton ABT6G 2S2
Overview
Area of Study / Keywords
parturition human pregnancy preterm birth term birth cytokines chemokines leukocytes neutrophils monocytes inflammatory mechanisms IL-1 IL-6 fetal inflammation stress resilience abuse allostatic load perinatal programming natural disaster rat mouse
About
PhD: St. Louis University
Post-doctoral Fellowship: University of Western Ontario
Olson Lab
Research Interests: Parturiton, preterm birth, fetal development, prenatal maternal stress
Research
I am a perinatal physiologist dedicated to improving women’s pregnancy health and fetal and newborn health. Over the years, much of my research focused on revealing the physiological steps that lead to labour and birth. My goal was always to find suitable diagnostic and therapeutic targets for the problem of preterm birth.
?
In recent years, my research has expanded to explore prenatal maternal stress (with Dr. Gerlinde Metz, University of Lethbridge) as one cause of preterm birth and the often-accompanying fetal inflammation. We explore these problems from their origins to their consequences and possible solutions.
� What causes preterm birth and fetal inflammation?
� How can we identify vulnerable women?
� Once we identify these women, how do we diagnose them clinically and treat them effectively?
� Can our therapeutics also solve the health consequences experienced by the offsprin (with Dr. Sylvain Chemtob, Universit� de Montr�al)?
This broad approach to studying preterm birth has led my lab to work with global experts in neuroscience, epidemiology, psychology, pharmacology, drug development, epigenetics, computer science, clinical sciences, and other healthcare scientists and providers.
As well, this work has resulted in the formation of two companies. I founded Livmor Diagnostics (now Livmor Biosciences) in 2012 to develop our patented Leukocyte Migration Assay into a clinical diagnostic. I also co-founded Maternica Therapeutics in 2019 with Dr. Chemtob and others to commercialize promising therapeutics to block preterm birth and fetal inflammation. Through these efforts, I hope to find real solutions for the problem of preterm birth, which impacts 15 million babies yearly. I also hope to provide an environment for my trainees where they can explore both the research and commercialization of science.
Teaching
I manage the course, Fetal Physiology, PHYSIOLOGY 513, a senior undergraduate and graduate level course. It is a seminar style course exploring contemporary concepts in maternal pregnancy physiology, fetal development, parturition (birth) and new adaptation to independent life. Students in the course are expected to be self-learners and have considerable independence in selecting sub-topics for study. They each make several oral presentations to the class and write short papers. Improvement of oral and written communication skills, independent study and critical thinking abilities is emphasized.
I also accept senior undergraduate students in my laboratory who are enrolled in one-year research courses through their home departments or faculties.
Featured Publications
Pike A., Mikolas C., Tompkins K., Olson J., Olson D.M., Brémault-Phillips S.
Frontiers in Public Health. 2022 May; 10 10.3389/fpubh.2022.725256
Novel allosteric IL-6 receptor antagonist inhibits inflammation in human fetal membranes.
9th Canadian National Perinatal Research Meeting (CNPRM), Online meeting, May 30 - June 3, 2022. . 2022 May;
Prenatal maternal stress by social isolation reduces mothers' gestational length and alters the offspring's inflammatory profile
Canadian National Perinatal Research Meeting (CNPRM), Online meeting, May 30 - June 3, 2022. 2022 May;
Lopes N.A., Falkenberg E.A., Wiley C., Patel V., Serrano-Lomelin J., Fang X., Weiler A.M., McCreary J.K., Metz G.A.S., Olson D.M.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022 May; 23 (11):6169 10.3390/ijms23116169
Targeting IL-6-mediated inflammation with novel therapeutic HSJ633 in human fetal membranes.
Department of Obstetrics and Gynecology Annual Research Day, Edmonton, Alberta, Canada, May 13, 2022. . 2022 May;
The immunology of parturition is conserved across mammalian species.
Department of Obstetrics and Gynecology Annual Research Day, Edmonton, Alberta, Canada, May 13, 2022. . 2022 May;
Lee H., Patel V., Onushko M., Fang X., Chemtob S., Olson D.
Frontiers in Pharmacology. 2022 May; 13 10.3389/fphar.2022.898008
Novel demonstration that interleukin (IL)-1 receptor antagonist, rytvela, is efficacious in human fetal membrane (hFM) explants and peripheral leukocytes.
Society for Reproductive Investigation 69th Annual Meeting, Reproductive Sciences 2022;29(Supp 1): 53A-54A, Denver, Colorado, USA, March 15-19, 2022. (Abstract O-025). . 2022 March;
IL-6 upregulates inflammatory signaling in term pregnant maternal leukocytes, but not fetal membranes.
Woman and Children’s Health Research Institute Virtual Research Day, Edmonton, Alberta, Canada, November 4, 2021. . 2021 November;
IL-1? is a central driver of inflammation in human fetal membranes and peripheral leukocytes.
Woman and Children’s Health Research Institute Virtual Research Day, Edmonton, Alberta, Canada, November 4, 2021. . 2021 November;
Takahashi Y., Saito M., Usuda H., Takahashi T., Watanabe S., Hanita T., Sato S., Kumagai Y., Koshinami S., Ikeda H., Carter S., Fee E.L., Furfaro L., Chemtob S., Keelan J., Olson D., Yaegashi N., Newnham J.P., Jobe A.H., Kemp M.W.
PLoS One. 2021 September; 16 (9 September):e0257847 10.1371/journal.pone.0257847
Leimert K.B., Xu W., Princ M.M., Chemtob S., Olson D.M.
Frontiers in Cellular and Infectious Microbiology. 2021 August; 11 10.3389/fcimb.2021.660983
Verstraeten B.S.E., Elgbeili G., Hyde A., King S., Olson D.M.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 2021 August; 66 (8):710-718 10.1177/0706743720970859
Adverse events due to inflammation are successfully prevented by an allosteric modulator of IL-6R in a LPS mouse model of preterm birth.
Society for Reproductive Investigation 68th Annual Meeting, Reproductive Sciences. 2021;26 (1 Suppl), Boston, Massachusetts, USA, July 6-9, 2021. (Abstract W-003). 2021 July;
Human leukocytes express different chemokine receptors at term and preterm labor.
Society for Reproductive Investigation 68th Annual Meeting, Reproductive Sciences, 2021;26 (1 Suppl), Boston, Massachusetts, USA July 6-9, 2021. (Abstract W-015) Virtual poster.. 2021 July;
Resilience, coping styles and cognitive appraisal moderate disaster effects on maternal posttraumatic stress: the Fort McMurray Wood Buffalo Wildfire Study.
Society for Reproductive Investigation 68th Annual Meeting, Reproductive Sciences. 2021;26 (1 Suppl), Boston, Massachusetts, USA, July 6-9, 2021. . 2021 July;
Mikolas C., Pike A., Jones C., Smith-MacDonald L., Lee M., Winfield H., Griffiths J., Perry R., Olson D.M., Heber A., Olson J., Sevigny P.R., Brémault-Philips S.
Frontiers in Psychology. 2021 July; 12 10.3389/fpsyg.2021.651522
The inhibitory effect of amniotic fluid contamination on anticoagulation pathway in the maternal plasma measured by an Activated Protein C-sensitivity test.
Society for Reproductive Investigation 68th Annual Meeting, Reproductive Sciences, 2021;26 (1 Suppl), Boston, Massachusetts, USA July 6-9, 2021. . 2021 July;